Abstract
Stereotactic ablative radiotherapy is the standard treatment for patients with stage I non-small cell lung cancer who are unfit for surgery or refuse surgery. Surveillance imaging is to assess treatment response and pulmonary toxicity, detect local recurrence and secondary lung cancer. The early detection of recurrence is important for patients for whom a salvage therapy is available. However, changes in lung density on computed tomography are common after stereotactic ablative radiotherapy and can confound the early detection of recurrence.1877-1203/© 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
